학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 65건 | 목록 1~10
Academic Journal
Ungricht R; Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4056 Basel, Switzerland.; Guibbal L; Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4056 Basel, Switzerland.; Lasbennes MC; Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4056 Basel, Switzerland.; Orsini V; Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4056 Basel, Switzerland.; Beibel M; Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4056 Basel, Switzerland.; Waldt A; Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4056 Basel, Switzerland.; Cuttat R; Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4056 Basel, Switzerland.; Carbone W; Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4056 Basel, Switzerland.; Basler A; Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4056 Basel, Switzerland.; Roma G; Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4056 Basel, Switzerland.; Nigsch F; Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4056 Basel, Switzerland.; Tchorz JS; Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4056 Basel, Switzerland.; Hoepfner D; Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4056 Basel, Switzerland.; Hoppe PS; Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4056 Basel, Switzerland. Electronic address: philipp.hoppe@novartis.com.
Publisher: Cell Press Country of Publication: United States NLM ID: 101311472 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-9777 (Electronic) Linking ISSN: 18759777 NLM ISO Abbreviation: Cell Stem Cell Subsets: MEDLINE
Academic Journal
Lopes R; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland. rui.lopes@novartis.com giorgio.galli@novartis.com.; Sprouffske K; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland.; Sheng C; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland.; Uijttewaal ECH; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland.; Wesdorp AE; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland.; Dahinden J; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland.; Wengert S; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland.; Diaz-Miyar J; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland.; Yildiz U; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland.; Bleu M; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland.; Apfel V; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland.; Mermet-Meillon F; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland.; Krese R; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland.; Eder M; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland.; Olsen AV; Biotech Research and Innovation Centre (BRIC), The Finsen Laboratory, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Hoppe P; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland.; Knehr J; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland.; Carbone W; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland.; Cuttat R; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland.; Waldt A; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland.; Altorfer M; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland.; Naumann U; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland.; Weischenfeldt J; Biotech Research and Innovation Centre (BRIC), The Finsen Laboratory, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; deWeck A; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland.; Kauffmann A; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland.; Roma G; Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Basel, Switzerland.; Schübeler D; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Faculty of Sciences, University of Basel, Basel, Switzerland.; Galli GG; Disease area Oncology, Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland. rui.lopes@novartis.com giorgio.galli@novartis.com.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Cuttat, R.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어